InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[Seel]

It may have been more simple. Hard to assess given lock up of data due to suit - but it looks as though a conflict might have occurred between the expected neurogenic bladder sequelae and the university researchers obligation to limit pain experience of primates. I think this is where the rift might have occurred. NVIV has alluded to this - saying the bladder symptoms would have been relieved with surgery - but (perhaps)regulatory compliance issues led to the team euthanizing before surgical opportunity given.